Immunome, Inc. (IMNM) Tops Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts IMNM Hot Sheet
Join SI Premium – FREE
Immunome, Inc. (NASDAQ: IMNM) reported Q1 EPS of ($0.52), $0.14 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $2.93 million versus the consensus estimate of $768.12 thousand.
For earnings history and earnings-related data on Immunome, Inc. (IMNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
- Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
